In:
Journal of Investigative Medicine High Impact Case Reports, SAGE Publications, Vol. 1, No. 1 ( 2013-01-01), p. 232470961348034-
Abstract:
Cyclophosphamide is increasingly used to treat various types of cancers and autoimmune conditions. Higher doses of this drug may produce significant cardiac toxicity, including fatal hemorrhagic myocarditis. In this review, we present a case of cyclophosphamide-induced cardiomyopathy requiring mechanical circulatory support. We also describe the pathophysiology, clinical manifestations, and risk factors for this important clinical entity and propose early detection and management strategies.
Type of Medium:
Online Resource
ISSN:
2324-7096
,
2324-7096
DOI:
10.1177/2324709613480346
Language:
English
Publisher:
SAGE Publications
Publication Date:
2013
detail.hit.zdb_id:
2710326-2
Permalink